What is Biocon famous for?
What is Biocon famous for?
2003 – Biocon becomes the first company worldwide to develop human insulin on a Pichia expression system. 2006 – BIOMAb EGFR, first indigenously developed humanised monoclonal antibody for head-and-neck cancer is launched and Dr. APJ Abdul Kalam inaugurates India’s Largest Biotech-Hub “Biocon Park”.
Is Biocon a good company?
The overall rating of Biocon Biologics India is 3.9, with Job Security being rated at the top and given a rating of 4.0. However, Salary & Benefits is rated the lowest at 3.7.
What manufactures Biocon?
Biocon Limited is India’s largest and fully-integrated innovation-led biopharmaceutical company. Some of its key brands are INSUGEN (rh-insulin) BASALOG (Glargine) CANMAb (Trastuzumab) BIOMAb-EGFR (Nimotuzumab) KRABEVAA (Bevacizumab) and ALZUMAb (Itolizumab) a ‘first in class’ anti-CD6 monoclonal antibody.
What is Biocon India Group?
The Biocon India Group is the largest biotechnology conglomerate in India today with highly automated and modern integrated manufacturing and research facilities set on a 30-acre site on the outskirts of the hightech city of Bangalore in South India.
How can I join Biocon?
Page 1
- Candidate Registration &
- Biocon Ltd.
- STEPS TO CREATE YOUR PROFILE AND APPLY.
- BEGIN BY REGISTRATION –CREATE A USERID AND PASSWORD.
- REMEMBER TO MAKE A NOTE OF IT ON A PIECE OF PAPER OR ON YOUR COMPUTER.
- NEXT, YOU WILL BE DIRECTED FIRST TO THE ‘CREATE PROFILE’
- SECTION.
Who is the owner of Biocon?
Siddharth Mittal (Dec 1, 2019–)
Biocon/CEO
Is it good to buy Biocon shares now?
While we don’t usually like to see insider selling, it’s more concerning if the sales take place at a lower price. We note that this sale took place at around the current price, so it isn’t a major concern, though it’s hardly a good sign. All up, insiders sold more shares in Biocon than they bought, over the last year.
Who is the CEO of Biocon?
Biocon/CEO
Siddharth Mittal is the Managing Director and CEO of Biocon Ltd. He joined Biocon in May 2013 and served as President & Chief Financial Officer between August 2014 and November 2019.
Is Biocon undervalued?
So, you can’t really fault the promoter of Biocon for wondering why the largest biopharma company out of India and the world’s fourth-largest insulin provider is undervalued. Biocon is valued at Rs 9,300 crore, which includes a research subsidiary, Syngene, whose shares recently traded at a valuation of Rs 3,800 crore.
Who led Biocon company?
Kiran Mazumdar-Shaw is the Chairperson and Managing Director of Biocon, Asia’s leading bio-pharmaceuticals enterprise. Named among TIME magazine’s 100 most influential people in the world, she is recognized as a global thought leader for Biotechnology.
Why Biocon share is down?
Biocon share price was down over 2 percent intraday on July 6. Biocon has been in focus for the wrong reason as market regulator Sebi has restrained an official of Biocon Ltd from accessing the securities market for three months and also levied monetary penalty for contravening insider trading norms.
Which is the headquarters of Biocon in India?
BioconCorporate Headquarters. Biocon Limited. 20th KM, Hosur Road, Electronic City, Bangalore, India – 560 100. CINL – 24234KA1978PLC003417. T +91 80 2808 2808 /. +91 80 4014 4014.
Which is the first export of Biocon India?
Biocon’s first export was Papain, a plant enzyme derived from Papaya, to U.S. and Europe, signalling the company’s ambition to produce high quality, world class products in India for global markets. Kiran Mazumdar-Shaw and Les Auchincloss at the foundation laying ceremony for Biocon’s first building on Hosur Road, Bangalore
What kind of medical products does Biocon make?
Biocon is addressing global medical needs through a portfolio of differentiated and high quality, life-saving biotherapeutics.
Why is Biocon the world’s largest biopharmaceutical company?
Our novel biologics address unmet medical needs across the world. The 10-cent Diabetes. At 10 cents a day our insulin is a game changer in the developing world. Driven by purpose. We are a global biopharmaceutical company with the belief that everyone, everywhere deserves access to affordable quality medicines. Driven by purpose.
